Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
Titel:
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
Auteur:
Emdal, Kristina B. Palacio-Escat, Nicolàs Wigerup, Caroline Eguchi, Akihiro Nilsson, Helén Bekker-Jensen, Dorte B. Rönnstrand, Lars Kazi, Julhash U. Puissant, Alexandre Itzykson, Raphaël Saez-Rodriguez, Julio Masson, Kristina Blume-Jensen, Peter Olsen, Jesper V.